Zydus Wellness Limited

ZYDUSWELL
481.05trending_down-1.07%May 26, 2026

Price History

Loading...

Recent Discussions

RC
Ritesh Chopra5d ago

Zydus Wellness anticipates a growth spurt for Glucon D and its seasonal beverage line in the next fiscal year (FY27), bolstered by increased demand due to heatwaves. The non-seasonal product portfolio showed a robust 16-17% growth in FY26, and the company is now considering global expansion, including launching protein products across Europe under WeightWorld brand.

DJ
Deepesh Jain7d ago

Zydus Wellness predicts a consistent double-digit growth rate for their seasonal product line over the next 3-4 years. For fiscal years 2027 and 2028, the company projects a corporate tax rate of 25%. The previous fiscal years' taxes will be managed with cash and deferred tax assets.

AB
Ajay Bansal7d ago

Motilal Oswal has boosted its target price for Zydus Wellness to Rs 600 following Q4 results, attributing this to a stable core business. The promising growth prospects of businesses like RiteBite and Comfort Click have been noted. For FY27 and FY28, the EBITDA estimates remain unchanged, with valuations at 23x and 18x EV/EBITDA respectively.

PM
Paresh Menon7d ago

Zydus Wellness sets a goal of achieving 17-18% profit margins (EBITDA) in the upcoming years, with Comfort Click excluded from the calculation. In Q4, Comfort Click surpassed expectations and boosted earnings per share (EPS), with their full-year projections remaining unchanged.

SS
Sachin Shukla7d ago

Zydus Wellness reported a 5.8% decline in Q4 profits to INR 162 crores, mainly due to increased expenses. The full-year net profit for FY26 dropped to INR 197.2 crores but revenue saw an uptick at INR 3,961 crores. The company proposed a final dividend of INR 1.20 for the shareholders.

SC

Zydus Wellness' Q4 EBITDA increased significantly by 42% to ₹2.7 billion compared to the same period last year, but the profit margin dipped to 18.2%. This decrease in margin might be a concern for investors.

ST
Sanjay Trivedi8d ago

Companies like IOC, Astral, Zydus Wellness, Strides Pharma, JSW Cement, GE Vernova, DOMS Industries, and Afcons Infra will be reporting their Q4 results today, shedding light on their financial performance for the quarter. Investors will closely watch these announcements to assess the companies' progress.

VR
Varun Reddy8d ago

Zydus Wellness reported a significant 63% increase in Q4 revenue, reaching ₹1,484.7 crore, primarily driven by strong sales of Sugar Free and Glucon D. However, profits dipped by 6%, as higher operational costs outweighed the revenue growth, with EBITDA rising by 42.2% to ₹270 crore but margin decreasing to 18.2%.

YG
Yash Gupta14d ago

Analyst Rohan Shah at ACMIIL anticipates potential 23% growth in shares of Zydus Wellness, NCC, Redington, VTL, and Aarti Industries due to their promising technical setups and bullish momentum in the case of Zydus Wellness.

SB
Sahil Bose43d ago

Zydus Wellness experienced a significant boost today, climbing 13% to reach a 52-week high of ₹552.4 on increased trading volumes. The stock outperformed the Nifty 50 index, with gains of 30% over the past month and an impressive 55% year-on-year increase, despite reporting a net loss of ₹39.9 crore in Q3FY26.

UT
Uday Thakur49d ago

Zydus Wellness aims to foster growth by leveraging its diverse portfolio, including the international expansion efforts of Comfort Click and the rapid scaling of RiteBite, alongside innovation and established brands.

VB
Vipul Bose49d ago

Zydus Wellness experienced a significant surge of 18%, marking its largest daily increase since 2009, amidst robust trading of over 2 crore shares, with no notable news releases as the driving force.

AY
Ankit Yadav49d ago

Adani Green Energy witnessed a significant increase in trading volume, with a 23.2 times surge to over 72 million shares, resulting in a 6.2% rise to Rs.908.2. Meanwhile, Zydus Wellness experienced a notable boost, recording a 17.2 times jump in volume to nearly 7 million shares and gaining 12% to reach Rs.497.25.

KS
Kunal Saxena51d ago

Zydus Wellness, an Indian pharmaceutical firm, has been hit with a EUR 19,472.6 VAT penalty in Spain. The company intends to challenge this decision through an appeal process.

AJ
Arun Joshi55d ago

FMCG companies face margin pressure due to increased costs, geopolitical issues, and a weak rupee. In response, they are planning price increases for their products starting in April, with an initial hike of around 3-4%. This move comes as urban FMCG value growth experienced a significant contraction of 4-5% in March.